Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orthobiologic Treatment for Knee Osteoarthritis
NCT06893250Phase 3Enrolling by invitation
- Sponsor
- University Hospital of North Norway
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 3 trial of autologous platelet-rich plasma in knee osteoarthritis (OA), sponsored by University Hospital of North Norway. Started Sep 2024; status: enrolling by invitation.
02
Drugs
autologous platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06893250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06893250.